ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
62,775.87
-0.12%
S&P 500
5,475.09
0.00%
Dow Jones
39,169.52
0.00%
US Dollar vs Yen
161.5545
0.03%
Brent Oil
87.06
0.61%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Inovio Pharmaceuticals Inc New (INO)

  7. Inovio Pharmaceuticals Inc New (INO) ニュース

INO

Inovio Pharmaceuticals (INO)

Inovio Pharmaceuticals Inc New
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:INO
日付受信時刻ニュースソース見出しコード企業名
2024/07/0205 : 00PR Newswire (US)INOVIO Reports Inducement Grant Under Inducement PlanNASDAQ:INOInovio Pharmaceuticals Inc New
2024/07/0121 : 00PR Newswire (US)INOVIO Added to Russell 2000® Index Effective July 1, 2024NASDAQ:INOInovio Pharmaceuticals Inc New
2024/06/0421 : 00PR Newswire (US)INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.NASDAQ:INOInovio Pharmaceuticals Inc New
2024/06/0105 : 48PR Newswire (US)INOVIO Reports Inducement Grants Under Inducement PlanNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/2905 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/2305 : 51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/2305 : 51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/2305 : 51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/2305 : 51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/2305 : 50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/2305 : 50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/2305 : 49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706 : 13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706 : 12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706 : 11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706 : 10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706 : 08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706 : 06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706 : 04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1705 : 59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1406 : 56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1405 : 57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1405 : 10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1405 : 05PR Newswire (US)INOVIO Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1405 : 01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/0121 : 00PR Newswire (US)INOVIO Reports Inducement Grants Under Inducement PlanNASDAQ:INOInovio Pharmaceuticals Inc New
2024/04/2921 : 00PR Newswire (US)INOVIO to Participate in Upcoming Investor Conferences in MayNASDAQ:INOInovio Pharmaceuticals Inc New
 Showing the most relevant articles for your search:NASDAQ:INO

最近閲覧した銘柄

NYSE
JPM
JP Morgan Chase
USOTC
RHHBY
Roche (QX)
CCOM
US500
US 500
NYSE
AXP
American Express
NASDAQ
AAPL
Apple
NYSE
VZ
Verizon Communications
NASDAQ
GOOGL
Alphabet
COIN
BTCUSD
Bitcoin
USOTC
ADDYY
Adidas (QX)
NYSE
MRK
Merck
FX
USDEUR
US Dollar vs Euro
NYSE
CVX
Chevron
AMEX
XLE
Energy Select Sector SPDR
CCOM
US30
US 30
USI
USTECH100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有